Cover Image

Evaluation of the Clinical Outcome of Nab-paclitaxel on Multiple Primary Malignancies: A Systematic Review and Meta-analysis

Background and aim: In the present study, an attempt has been made to analyze the side effects of nab-paclitaxel compared to sb-paclitaxel and docetaxel. The present study aimed to evaluate the clinical outcome of Nab-paclitaxel on Multiple primary malignancies.Material and methods: All articles pub...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fatemeh Salehi Kahrizsangi (Author), Neda Mehrafar (Author), Pezhman Ghadami (Author), Fatemeh Rabiee (Author), Yasaman Shariati (Author)
Format:	Book
Published:	International Journal of Scientific Research in Dental and Medical Sciences (IJSRDMS), 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluate the Clinical Outcome of Nanoparticle Albumin-bound Paclitaxel on Breast Cancer Treatment: A Systematic Review and Meta-analysis
by: Yasaman Shariati, et al.
Published: (2022)

Evaluation of the Effect of Mesenchymal Stem Cells on Breast Cancer Migration and Metastasis: A Systematic Review and Meta-analysis
by: Pezhman Ghadami, et al.
Published: (2023)

Evaluation of the Role of Exosome-derived MiRNA in Breast Cancer Diagnosis: A Systematic Review and Meta-analysis
by: Pezhman Ghadami, et al.
Published: (2023)

A Case of Stress Cardiomyopathy With Nab-Paclitaxel Infusion
by: Harjinder Singh MD, et al.
Published: (2023)

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
by: De Luca R, et al.
Published: (2018)

Evaluate the Prognostic Value of Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA: A Systematic Review and Meta-analysis
by: Negar Eghbalifard, et al.
Published: (2024)

Safety of nab-paclitaxel following an allergic reaction to paclitaxel: A single institution retrospective study
by: Swapna Kochuveettil, et al.
Published: (2024)

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy
by: Jingjing Zhang, et al.
Published: (2023)

Clinical Characteristics and Risk Factors of Lung Injury Induced by Nab-Paclitaxel
by: Yoshioka K, et al.
Published: (2022)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
by: Lazzaro C, et al.
Published: (2013)

Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel
by: Anne Steins, et al.
Published: (2017)

Atezolizumab plus carboplatin and nab‐paclitaxel versus carboplatin and nab‐paclitaxel as treatments for Chinese, treatment‐naïve, stage IV, non‐squamous, non‐small‐cell lung cancer patients: A retrospective analysis
by: Yingkai Chen, et al.
Published: (2022)

Case report: Idiopathic pulmonary fibrosis induced by nab-paclitaxel: A rare complication
by: Jiahui Shen, et al.
Published: (2023)

Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023)

Physicochemical Stability of Nab-Paclitaxel (Pazenir) Infusion Dispersions in Original Glass Vials and EVA Infusion Bags
by: Helen Linxweiler, et al.
Published: (2024)

Pharmacoeconomic analysis of atezolizumab plus nab-paclitaxel in the treatment of the advanced or metastatic triple-negative breast cancer
by: A S Kolbin, et al.
Published: (2020)

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
by: Dranitsaris G, et al.
Published: (2015)

Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review
by: Sirui Tan, et al.
Published: (2022)

Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma
by: Nan Zhou, et al.
Published: (2023)

Nab-paclitaxel-associated photosensitivity: report in a woman with non-small cell lung cancer and review of taxane-related photodermatoses
by: Bryce D. Beutler, et al.
Published: (2015)

The Last Laird of MacNab An Episode in the Settlement of MacNab Township, Upper Canada
by: Fraser, Alexander, 1860-1936 [Editor]

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life
by: Palumbo R, et al.
Published: (2015)

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
by: Gridelli C, et al.
Published: (2018)

Antioxidant properties of Helichrysum pseudoplicatum Nab
by: Mohammad Ali Ebrahimzadeh, et al.
Published: (2015)

Evaluation of the Effects of Nanoparticles in the Treatment of Diabetes Mellitus: A Systematic Review and Meta-analysis
by: Fatemeh Rabiee, et al.
Published: (2022)

Complete response of refractory mycosis fungoides to treatment of pancreatic cancer with combination gemcitabine and nab-paclitaxel: A possible new regimen for the treatment of advanced cutaneous T-cell lymphoma
by: Michelle Pratt, MD, et al.
Published: (2020)

Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer
by: Chen-Yu Wang, et al.
Published: (2024)

Excretion of the Polymyxin Derivative NAB739 in Murine Urine
by: Martti Vaara, et al.
Published: (2020)

Impact of Ninjin'Yoeito on Fatigue in Patients Receiving Nab-Paclitaxel Plus Gemcitabine Therapy: A Prospective, Single-Arm, Phase II Open Label, Nonrandomized, Historically-Controlled Study
by: Ken-ichi Okada, MD, PhD, et al.
Published: (2020)

Possible Benefits of Paclitaxel Therapy for COVID-19
by: Marzieh Pashmforosh, et al.
Published: (2022)

A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report
by: Luke Meredith, et al.
Published: (2023)

Optimizing Outcomes: Bevacizumab with Carboplatin and Paclitaxel in 5110 Ovarian Cancer Patients-A Systematic Review and Meta-Analysis
by: Yu Jin Kim, et al.
Published: (2024)

Perbedaan Gejala Konjungtivitis Pada Karyawan Terpapar Debu Batubara di Atas NAB dan Di bawah NAB di PT INDO ACIDATAMA tbk Kemiri, Kebakkramat, Karanganyar
by: Susanto, Erwan
Published: (2016)

Multiple primary malignancies of female genital organs: ways of prevention
by: Yu. G. Payanidi, et al.
Published: (2014)

16 A subset of bNAbs exhibit broad binding to primary CD4+ T cells infected with reactivated reservoir HIV in vitro
by: Yanqin Ren, et al.
Published: (2017)

Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel
by: Jessica D. Lang, et al.
Published: (2023)

Primary multiple malignant skin tumors: melanoma and basal cell carcinoma
by: Tatiana A. Gaydina, et al.
Published: (2023)

Multiple metastatic deposits in hepatocellular carcinoma: Hunt for diagnosis of primary malignancy
by: Satish Arakeri, et al.
Published: (2023)

A Case Report of Primary Malignant Melanoma of the Gallbladder with Multiple Metastases
by: Steven H. Adams, et al.
Published: (2023)

Protocol of the IntenSify‐Trial: An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy
by: Nicolas Hohmann, et al.
Published: (2023)